Cytotechnology · Yin et al.
doi.org/10.1007/s10616-026-01080-x
#RNAsky #RNAmods
Cytotechnology · Yin et al.
doi.org/10.1007/s10616-026-01080-x
#RNAsky #RNAmods
#HeterochronicParabiosis #GDF15 #GDF11 #Klotho #SystemicFactors #Geroscience #CirculatingProteome #IntegratedStressResponse
#HeterochronicParabiosis #GDF15 #GDF11 #Klotho #SystemicFactors #Geroscience #CirculatingProteome #IntegratedStressResponse
Using our novel structure, computational analysis, and molecular dynamics simulations, we interrogate the antagonist's ligand specificity.
www.jbc.org/article/S002...
Using our novel structure, computational analysis, and molecular dynamics simulations, we interrogate the antagonist's ligand specificity.
www.jbc.org/article/S002...
www.facebase.org/2026/08/25/r...
www.facebase.org/2026/08/25/r...
www.lifespan.io/news/enginee...
By: Josh Conway
www.lifespan.io/news/enginee...
By: Josh Conway
by Aluri S, Ling T (...) Verma A et 26 al. in J Clin Invest #MedSky
👉 get more here
📖 read the article: https://www.jci.org/articles/view/189266
by Aluri S, Ling T (...) Verma A et 26 al. in J Clin Invest #MedSky
👉 get more here
📖 read the article: https://www.jci.org/articles/view/189266
The treated mice had substantially less senescence.
www.lifespan.io/news/enginee...
The treated mice had substantially less senescence.
www.lifespan.io/news/enginee...
By: Josh Conway on Thursday, July 17, 2025
By: Josh Conway on Thursday, July 17, 2025
🔗 to original research: www.gimjournal.org/article/S109... 2/5
🔗 to original research: www.gimjournal.org/article/S109... 2/5
->Nature | More info from EcoSearch
📄 Investigating and correcting a rare pathogenic mutation in GDF11
📄 Investigating and correcting a rare pathogenic mutation in GDF11
https://longevitynotes.online/is-gdf11-the-longevity-science-breakthrough/?utm_source=bluesky&utm_medium=social
#gdf11 #longevityresearch #neuroplasticity
https://longevitynotes.online/is-gdf11-the-longevity-science-breakthrough/?utm_source=bluesky&utm_medium=social
#gdf11 #longevityresearch #neuroplasticity
https://www.stocktitan.net/news/IBIO/i-bio-becomes-a-clinical-stage-company-with-first-participant-dosed-nex9njjebp2z.html
https://www.stocktitan.net/news/IBIO/i-bio-becomes-a-clinical-stage-company-with-first-participant-dosed-nex9njjebp2z.html
https://www.stocktitan.net/news/IBIO/i-bio-received-regulatory-clearance-to-initiate-its-phase-1-clinical-fzkqmx5rsrdw.html
https://www.stocktitan.net/news/IBIO/i-bio-received-regulatory-clearance-to-initiate-its-phase-1-clinical-fzkqmx5rsrdw.html